Troy E. Wilson, Ph.D., J.D.

Serial biotech entrepreneur and company builder: Troy Wilson has repeatedly co‑founded and led biotechnology companies (including Kura Oncology, Avidity Biosciences, Wellspring Biosciences, Araxes Pharma, Intellikine, and Ambrx) through discovery, development, financing and exit events. kuraoncology+2

Scientist‑lawyer with technical and legal credentials: He holds a Ph.D. in bioorganic chemistry and a B.A. in biophysics from UC Berkeley, plus a J.D. from New York University, combining scientific expertise with legal and business acumen in executive roles. kuraoncology+1

Board and governance experience across public and private companies: Wilson serves on multiple corporate boards (Puma Biotechnology, Avidity Biosciences, Cartography, Montara) and has long tenure in board leadership positions, advising strategy, financing and commercialization. pumabiotechnology+3

Leader in precision oncology drug development: As Kura's CEO he advanced ziftomenib (a menin inhibitor) and FTI programs through pivotal trials, regulatory submission and commercialization planning, culminating in NDA submission and later approval activity in 2025. kuraoncology+1